DK0517292T3 - Rekombinant Avipox-virus - Google Patents

Rekombinant Avipox-virus

Info

Publication number
DK0517292T3
DK0517292T3 DK92201406T DK92201406T DK0517292T3 DK 0517292 T3 DK0517292 T3 DK 0517292T3 DK 92201406 T DK92201406 T DK 92201406T DK 92201406 T DK92201406 T DK 92201406T DK 0517292 T3 DK0517292 T3 DK 0517292T3
Authority
DK
Denmark
Prior art keywords
avipox virus
recombinant avipox
recombinant
virus
avipox
Prior art date
Application number
DK92201406T
Other languages
Danish (da)
English (en)
Inventor
Didier Colau
Wannemaeker Catherine De
Daniel Malarme
Georges Thiry
Original Assignee
Dimminaco Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimminaco Ag filed Critical Dimminaco Ag
Application granted granted Critical
Publication of DK0517292T3 publication Critical patent/DK0517292T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455—Eimeria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK92201406T 1991-05-27 1992-05-19 Rekombinant Avipox-virus DK0517292T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE9100507A BE1004877A3 (fr) 1991-05-27 1991-05-27 Virus de l'avipox recombinant, culture de cellules infectees par ce virus et vaccins pour la volaille derives de ce virus.

Publications (1)

Publication Number Publication Date
DK0517292T3 true DK0517292T3 (da) 2000-05-08

Family

ID=3885526

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92201406T DK0517292T3 (da) 1991-05-27 1992-05-19 Rekombinant Avipox-virus

Country Status (23)

Country Link
EP (1) EP0517292B1 (enExample)
JP (1) JP3411307B2 (enExample)
KR (1) KR100244601B1 (enExample)
CN (1) CN1055501C (enExample)
AR (1) AR248045A1 (enExample)
AT (1) ATE189480T1 (enExample)
AU (1) AU656185B2 (enExample)
BE (1) BE1004877A3 (enExample)
BR (1) BR9202024A (enExample)
CA (1) CA2069594A1 (enExample)
DE (1) DE69230627T2 (enExample)
DK (1) DK0517292T3 (enExample)
ES (1) ES2145000T3 (enExample)
HU (1) HU215531B (enExample)
IE (1) IE921686A1 (enExample)
IL (1) IL101780A (enExample)
MX (1) MX9202512A (enExample)
NZ (1) NZ242620A (enExample)
PT (1) PT517292E (enExample)
RU (1) RU2130971C1 (enExample)
SG (1) SG49876A1 (enExample)
TW (1) TW288048B (enExample)
ZA (1) ZA923321B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2110505A1 (en) * 1991-07-26 1993-02-18 Enzo Paoletti Infectious bursal disease virus recombinant poxvirus vaccine
ATE286137T1 (de) * 1992-01-13 2005-01-15 Virogenetics Corp Rekombinantes vaccinia-virus als impfstoff gegen das marek-virus
FR2697534A1 (fr) * 1992-11-02 1994-05-06 Rhone Merieux Virus herpès de la dinde recombinant pour la réalisation de vaccin de la maladie de Gumboro, son procédé de préparation et vaccin obtenu.
US6136318A (en) * 1993-02-26 2000-10-24 Cochran; Mark D. Recombinant fowlpox viruses and uses thereof
AU6299594A (en) * 1993-02-26 1994-09-14 Nippon Zeon Co., Ltd. Recombinant fowlpox virus s-fpv-043 and uses thereof
US5925358A (en) * 1993-02-26 1999-07-20 Syntro Corporation Recombinant fowlpox viruses and uses thereof
FR2728795B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire
FR2728794B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro
GB9711957D0 (en) 1997-06-09 1997-08-06 Isis Innovation Methods and reagents for vaccination
US7041439B2 (en) * 2001-04-17 2006-05-09 Embrex, Inc. Methods and apparatus for selectively processing eggs having identified characteristics
GB0118532D0 (en) 2001-07-30 2001-09-19 Isis Innovation Materials and methods relating to improved vaccination strategies
GB2382578A (en) * 2001-11-30 2003-06-04 Isis Innovation Fowlpox-based vaccine
EP1450854A2 (en) 2001-11-30 2004-09-01 Isis Innovation Limited Vaccine
PL216760B1 (pl) * 2002-05-16 2014-05-30 Bavarian Nordic As Rekombinowany modyfikowany wirus krowianki Ankara oraz sposób jego otrzymywania i zastosowania
EP1601333B1 (en) * 2003-02-20 2013-01-23 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services Novel insertion sites in pox vectors
GB2402391A (en) * 2003-06-04 2004-12-08 Oxxon Pharmaccines Ltd Fowlpox recombinant genome
EP2785373B1 (en) 2011-11-30 2019-11-20 Boehringer Ingelheim Animal Health USA Inc. Recombinant hvt vectors expressing antigens of avian pathogens and uses thereof
EP2845904A1 (en) 2013-09-06 2015-03-11 Ceva Sante Animale Recombinant Marek's disease viruses and uses thereof
EP3050572A1 (en) 2015-01-29 2016-08-03 Ceva Sante Animale Recombinant MDV1 and the uses thereof
EP3263129A1 (en) 2016-06-29 2018-01-03 Ceva Sante Animale Duck enteritis virus and the uses thereof
CN117357642A (zh) 2016-12-14 2024-01-09 勃林格殷格翰动物保健美国公司 表达禽病原体的多种抗原的重组hvt载体及其用途
CN113347992A (zh) 2018-12-27 2021-09-03 法国诗华大药厂 重组病毒和其用途
MA58717A1 (fr) 2020-06-17 2023-06-28 Boehringer Ingelheim Vetmedica Gmbh Vecteurs hvt recombinants exprimant l'hémagglutinine de la grippe et compositions immunogènes, et leur fabrication et leurs utilisations
TWI812936B (zh) 2021-04-01 2023-08-21 智勝科技股份有限公司 研磨墊及研磨方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
FR2632863B2 (fr) * 1987-10-29 1990-08-31 Transgene Sa Virus du fowlpox recombinant et vaccins derives de ces virus
US5310671A (en) * 1988-06-24 1994-05-10 British Technology Group Limited Fowlpox virus non-essential regions
US5093258A (en) * 1988-08-26 1992-03-03 Therion Biologics Corporation Recombinant fowlpox virus and recombination vector
AU623476B2 (en) * 1988-12-29 1992-05-14 Nippon Zeon Co., Ltd. Promoter, plasmid containing the same, and recombinant avipoxvirus
AU643216B2 (en) * 1989-05-30 1993-11-11 Commonwealth Scientific And Industrial Research Organisation Production of IBDV VP2 in highly immunogenic form

Also Published As

Publication number Publication date
ZA923321B (en) 1993-01-27
EP0517292A1 (fr) 1992-12-09
HUT62331A (en) 1993-04-28
AU656185B2 (en) 1995-01-27
IL101780A (en) 2000-12-06
ATE189480T1 (de) 2000-02-15
RU2130971C1 (ru) 1999-05-27
CA2069594A1 (fr) 1992-11-28
TW288048B (enExample) 1996-10-11
HU215531B (hu) 2000-05-28
EP0517292B1 (fr) 2000-02-02
PT517292E (pt) 2000-06-30
HU9201746D0 (en) 1992-08-28
JPH05244939A (ja) 1993-09-24
MX9202512A (es) 1995-01-31
BE1004877A3 (fr) 1993-02-16
DE69230627T2 (de) 2000-09-28
ES2145000T3 (es) 2000-07-01
IL101780A0 (en) 1992-12-30
CN1069068A (zh) 1993-02-17
BR9202024A (pt) 1993-01-19
NZ242620A (en) 1993-09-27
JP3411307B2 (ja) 2003-05-26
DE69230627D1 (de) 2000-03-09
IE921686A1 (en) 1992-12-02
AR248045A1 (es) 1995-05-31
KR100244601B1 (ko) 2000-03-02
CN1055501C (zh) 2000-08-16
KR920021706A (ko) 1992-12-18
SG49876A1 (en) 2002-04-16
AU1632392A (en) 1992-12-03

Similar Documents

Publication Publication Date Title
DK0517292T3 (da) Rekombinant Avipox-virus
FR2621487B1 (fr) Virus avipox recombinant
ATA902590A (de) Rekombinantes pockenvirus
FI933757L (fi) Expression av rekombinantproteiner i attenuerade bakterier
ATA257190A (de) Virales polypeptid
NO942066L (no) Peptidderivater
ATA902490A (de) Rekombinantes pockenvirus-wirtsselektionssystem
DK603888A (da) Rekombinant virus
FI892714A0 (fi) Rekombinant-coccidiosisvaccin.
FI935244A7 (fi) Bestaemningsanordning
DE3853088D1 (de) Rekombinantes Avipoxvirus.
DE69116495D1 (de) Rekombinante Transglutaminase
DE3850019D1 (de) Rekombinantes Avipoxvirus.
FI925343A7 (fi) Tri-arginiini-insuliineja
DE69101683D1 (de) Rekombinantes Mareks-Krankheitsvirus.
DK111489D0 (da) Peptider
DK162890D0 (da) Polypeptid
FI941758L (fi) Rekombitooppipeptidejä
FI910398L (fi) Rekombinant coccidiosisvaccin -5-7-eimeria-ytantigen.
FI933495L (fi) Rekombinantadenovirusvacciner
FI905741A7 (fi) Peptidit
FI943626L (fi) Rekombinanttiadenovirusrokotteita
FI934588L (fi) Insulinlik vaextfaktor bindande protein haerstammande fraon maenniskoben
FI934777A0 (fi) Multipel hepatitis b virus ytproteiner som bildar partiklar
FI923311L (fi) Proteiner